日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Hydroxychloroquine fails to prevent COVID-19: trial

Xinhua | Updated: 2020-06-04 14:06
Share
Share - WeChat
The drug hydroxychloroquine is displayed at the Rock Canyon Pharmacy in Provo, Utah, US, May 27, 2020. [Photo/Agencies]

CHICAGO - Hydroxychloroquine, an anti-malaria drug, was not statistically effective in preventing infection for people exposed to the novel coronavirus, a clinical trial showed on Wednesday.

The experiment, led by a team at the University of Minnesota, the United States, in March, was the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19, according to the university.

Researchers enrolled 821 adults from the United States and Canada, who had come into contact with someone confirmed with COVID-19 for more than 10 minutes at a distance of six feet (1.83 meters) or less.

All the participants were randomly assigned to receive either hydroxychloroquine, or a vitamin placebo, for five days.

Over the next two weeks, against laboratory test and from clinical signs, researchers found that 49 of the 414, or 11.83 percent, given the medicine got the COVID-19, compared to 58 of the 407, or 14.25 percent, on the placebo.

The scientists said the difference of about 2.4 percentage points in favor of the medicine was not considered statistically significant, which means hydroxychloroquine has no benefit over placebo in COVID-19 prevention.

Side effects, however, were more common with hydroxychloroquine group than those on the placebo -- 40.1 percent versus 16.8 percent -- no serious ones were reported though.

The trial results has been published in the New England Journal of Medicine.

US President Donald Trump has said he used it as a prophylaxis against COVID-19, but the Food and Drug Administration cautioned in late April against the use of it outside of the hospital setting due to the risk of cardiac rhythm problems.

As of 0100 GMT Thursday, confirmed COVID-19 cases have passed 6.3 million globally, with 383,318 deaths, showed the tally of Center for Systems Science and Engineering at Johns Hopkins University.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 日韩欧美黄色片 | 两性网站| 欧美一区二区三区在观看 | 一区二区中文字幕 | 激情久久av一区av二区av三区 | 欧日一级片 | 国产一区二区精品丝袜 | 日本一区二区高清视频 | 久草福利资源网站免费 | 久久艹免费视频 | 亚洲视频观看 | 日韩精品一二三区 | 色屁屁影院网站入口 | 欧美成人综合在线 | 中文字幕av亚洲精品一部二部 | 久久久中文字幕日本 | 欧美成人精品欧美一级乱黄 | 奇米线在人线免费视频 | 9久热这里只有精品视频在线观看 | 亚洲一区二区三区高清 | 日本aⅴ在线观看 | 久久成人免费视频 | 污污视频免费网站 | 久久激情五月丁香伊人 | 亚洲一区二区久久 | 色婷婷av久久久久久久 | 国产精品综合色区在线观看 | 欧美一区二区三区 | 奇米亚洲 | 91啦视频在线观看 | 色屁屁www影院免费观看视频 | 91国在线国内在线播放 | 精品久久久久一区 | 成人精品在线观看 | 八武将免费完整版在线观看 | 免费午夜不卡毛片 | 999毛片免费观看 | 国产精品国产精品国产专区不卡 | 91精品国产综合久久久密闭 | 精品视频在线免费看 | 99久久精品国产免看国产一区 |